Lipella Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Lipella Pharmaceuticals has a total shareholder equity of $1.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.2M and $480.3K respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$1.19m |
| Aandelen | US$1.70m |
| Totaal verplichtingen | US$480.31k |
| Totaal activa | US$2.18m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: LIPO's short term assets ($2.1M) exceed its short term liabilities ($480.3K).
Langlopende schulden: LIPO's short term assets ($2.1M) exceed its long term liabilities ($1.0).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: LIPO is debt free.
Schuld verminderen: LIPO had no debt 5 years ago.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: LIPO has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: LIPO is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.